• Home
  • »
  • Newsroom
  • »
  • Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Re...

Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results on Thursday, February 16, 2017

Thursday, January 26, 2017 10:00 am EST

Dateline:

NEW HAVEN, Conn.

Public Company Information:

NASDAQ:
ALXN

NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2016 on Thursday, February 16, 2017 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, February 16, 2017, at 10:00 a.m. Eastern Time (ET).

To participate in this conference call, dial 877-681-3372 (USA) or 719-325-4794 (International), passcode 5877612 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 5877612. The audio webcast can be accessed on the Investor page of http://ir.alexionpharm.com.

[ALXN-G]

Contact:

Alexion Pharmaceuticals, Inc.
Elena Ridloff, CFA
Vice President, Investor Relations
(475) 230-3601